NBA1 Antibody

What is NBA1 and why is it important in research?

NBA1 (also known as MERIT40) is a crucial component of the BRCA1 A complex that plays significant roles in DNA damage sensing and repair mechanisms. NBA1 was identified through genetic and proteomic approaches as a protein that facilitates the recruitment of BRCA1 to sites of DNA damage and contributes to ionizing radiation (IR) resistance and cell cycle regulation . The importance of NBA1 in maintaining genomic stability makes it a valuable target for cancer research, particularly in studies related to DNA damage response pathways. NBA1 antibodies are essential tools for investigating the localization, interactions, and functions of this protein in various cellular contexts.

What are the most common applications for NBA1 antibodies in research?

NBA1 antibodies are primarily used in several key research applications:

• Western blotting: For detecting and quantifying NBA1 protein levels in cell lysates, typically visualized at its expected molecular weight.

• Immunoprecipitation: To isolate NBA1 and its associated protein complexes for further analysis.

• Immunofluorescence microscopy: For visualizing the subcellular localization of NBA1, particularly its recruitment to DNA damage sites.

• Chromatin immunoprecipitation (ChIP): To investigate NBA1 association with chromatin at specific genomic loci.

• Flow cytometry: For analyzing NBA1 expression in different cell populations.

Each application requires specific considerations regarding antibody dilution, incubation conditions, and validation approaches to ensure reliable and reproducible results .

How should I select an appropriate NBA1 antibody for my experiment?

When selecting an NBA1 antibody for your experiment, consider the following criteria:

• Application compatibility: Ensure the antibody is validated for your specific application (Western blot, immunofluorescence, etc.)

• Host species: Choose an antibody raised in a species that minimizes cross-reactivity with your experimental system

• Clonality: Monoclonal antibodies offer high specificity for a single epitope, while polyclonal antibodies may provide stronger signals by recognizing multiple epitopes

• Epitope location: Consider whether the epitope is in a region of interest or may be masked by protein interactions

• Validation data: Review published literature and manufacturer data for evidence of specificity and performance

• Sample preparation compatibility: Ensure the antibody works with your fixation and preparation methods (e.g., for formalin-fixed versus fresh samples)

It's advisable to test multiple antibodies when possible, especially for novel research questions or when studying protein variants .

What are the optimal conditions for detecting NBA1 by Western blot?

For optimal detection of NBA1 by Western blot, researchers should consider the following protocol recommendations:

• Sample preparation: Lyse cells in a buffer containing appropriate protease inhibitors to prevent NBA1 degradation

• Protein loading: Load 20-50 μg of total protein per lane

• Gel percentage: Use 8-10% SDS-PAGE gels to effectively resolve NBA1 (expected molecular weight ~40 kDa)

• Transfer conditions: Transfer to PVDF membrane at 100V for 1-2 hours or 30V overnight at 4°C

• Blocking: Block with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

• Primary antibody: Dilute NBA1 antibody (typically 1:1000 to 1:5000) in blocking buffer and incubate overnight at 4°C

• Secondary antibody: Use appropriate HRP-conjugated secondary antibody (typically 1:5000 to 1:10000) and incubate for 1 hour at room temperature

• Detection: Visualize using enhanced chemiluminescence detection system

For optimal results, include positive controls (cell lines known to express NBA1) and negative controls (NBA1 knockdown samples) . Studies have shown that NBA1 shRNA knockdown efficiency can be effectively monitored through Western blotting, which is critical for validating experimental manipulations .

How can I optimize immunofluorescence protocols to visualize NBA1 at DNA damage sites?

To effectively visualize NBA1 localization to DNA damage sites by immunofluorescence, follow these methodological recommendations:

• Cell preparation:

  • Grow cells on glass coverslips

  • Induce DNA damage using ionizing radiation (2-10 Gy) or laser microirradiation

  • For extraction before fixation (to reduce background): Treat cells with extraction buffer (0.5% Triton X-100 in CSK buffer) for 5 minutes on ice before fixation

• Fixation and permeabilization:

  • Fix cells with 4% paraformaldehyde for 10-15 minutes at room temperature

  • Permeabilize with 0.2% Triton X-100 in PBS for 5 minutes

• Blocking and antibody incubation:

  • Block with 3-5% BSA in PBS for 30-60 minutes

  • Incubate with NBA1 primary antibody (1:100-1:500 dilution) overnight at 4°C

  • Incubate with fluorescently-labeled secondary antibody (1:500-1:1000) for 1 hour at room temperature

• Co-staining markers:

  • Include γ-H2AX antibody as a marker for DNA damage sites

  • Consider co-staining with BRCA1 antibody to demonstrate colocalization

• Imaging considerations:

  • Use confocal microscopy for optimal visualization of nuclear foci

  • Capture z-stack images to ensure complete visualization of nuclear foci

Research has demonstrated that GFP-tagged NBA1 relocates to nuclear foci in response to IR when cells are extracted prior to fixation, and these foci colocalize with BRCA1 and γ-H2AX at sites of DNA damage .

What controls should I include when using NBA1 antibodies in my experiments?

Proper experimental controls are crucial for validating results obtained with NBA1 antibodies:

Essential controls for NBA1 antibody experiments:

• Positive controls:

  • Cell lines with confirmed NBA1 expression (e.g., 293T, U2OS cells)

  • Recombinant NBA1 protein (for Western blot)

  • GFP-NBA1 transfected cells (for localization studies)

• Negative controls:

  • NBA1 knockdown using validated shRNAs or siRNAs

  • NBA1 knockout cell lines (if available)

  • Secondary antibody-only control (to detect non-specific binding)

  • Isotype control antibody (matching the NBA1 antibody's host species and isotype)

• Specificity controls:

  • Peptide competition assay (pre-incubating the antibody with excess NBA1 peptide/protein)

  • Multiple NBA1 antibodies targeting different epitopes (to confirm signal specificity)

• Functional controls:

  • DNA damage induction (IR, UV, etc.) to verify expected translocation to damage sites

  • Co-immunoprecipitation with known interaction partners (e.g., Abra1, Rap80)

Research has shown that NBA1 knockdown controls using shRNAs or siRNAs that target different regions of the NBA1 sequence are effective for validating antibody specificity. Additionally, expression of shRNA-resistant NBA1 cDNA can reverse phenotypes associated with NBA1 depletion, providing a robust control for specificity .

How can I use NBA1 antibodies to study protein-protein interactions within the BRCA1 A complex?

NBA1 antibodies can be powerful tools for investigating protein-protein interactions within the BRCA1 A complex through several advanced techniques:

• Co-immunoprecipitation (Co-IP):

  • Use NBA1 antibodies conjugated to beads (protein A/G or directly coupled)

  • Lyse cells in non-denaturing buffer to preserve protein complexes

  • Incubate lysates with NBA1 antibody-bead complexes (4-16 hours at 4°C)

  • Wash stringently to remove non-specific interactions

  • Elute and analyze by Western blot or mass spectrometry for interacting partners

  • Include RNase and DNase treatment controls to exclude RNA/DNA-mediated interactions

• Proximity Ligation Assay (PLA):

  • Use paired antibodies (NBA1 + potential interaction partner)

  • Visualize direct protein interactions in situ as fluorescent spots

  • Quantify interaction frequency under different cellular conditions

• Tandem Affinity Purification (TAP):

  • Use cell lines stably expressing tagged NBA1 (e.g., Flag-HA-tagged)

  • Perform sequential purification steps to isolate high-confidence interaction partners

  • Identify components by mass spectrometry analysis

• FRET-based approaches:

  • Generate fluorescently-tagged NBA1 and potential partners

  • Measure energy transfer as indication of protein proximity

  • Analyze interaction dynamics in live cells

Research has demonstrated that TAP of Flag-HA-tagged NBA1 in 293T cells effectively identified associated proteins including Abra1, which connects to the BRCA1 complex. Reverse TAP using Abra1 confirmed this interaction and identified additional components of the BRCA1 A complex including BRCA1/BARD1, Rap80, BRE(BRCC45), and BRCC36, with NBA1 appearing as a stoichiometric member .

What experimental approaches can resolve contradictory NBA1 antibody results between different detection methods?

When faced with contradictory NBA1 antibody results between different detection methods, researchers should implement a systematic troubleshooting approach:

• Antibody validation strategy:

  • Test multiple NBA1 antibodies targeting different epitopes

  • Use knockout/knockdown controls to confirm specificity in each experimental system

  • Consider whether post-translational modifications might affect epitope recognition

• Method-specific considerations:

  Method	Potential Issues	Resolution Approaches
  Western blot	Protein degradation; incorrect MW	Use fresh samples; optimize lysis conditions; include protease inhibitors
  IF/IHC	Fixation artifacts; epitope masking	Test multiple fixation protocols; try antigen retrieval; use N- and C-terminal antibodies
  IP	Weak interactions; harsh buffer conditions	Use crosslinking; optimize salt/detergent concentrations
  Flow cytometry	Surface vs. intracellular detection	Ensure proper permeabilization; validate with imaging

• Biological explanations:

  • Consider cell type-specific differences in NBA1 expression or localization

  • Evaluate whether experimental manipulations alter NBA1 expression or interactions

  • Assess whether different protein isoforms or complexes might be detected differentially

• Orthogonal validation:

  • Use RNA-level detection (RT-PCR, RNA-seq) to confirm expression patterns

  • Employ tagged NBA1 constructs to verify localization patterns

  • Leverage proteomics approaches for unbiased validation

Research has shown that NBA1 plays multiple roles in the cell and associates with different protein complexes, which might explain differing results between experimental approaches. Additionally, the study demonstrated that NBA1 depletion affects the abundance of interacting proteins like BRE and Abra1, which could further complicate interpretation of results .

How can NBA1 antibodies be used to study DNA damage response dynamics?

To investigate DNA damage response dynamics using NBA1 antibodies, researchers can implement these advanced methodological approaches:

• Time-course immunofluorescence analysis:

  • Induce DNA damage (IR, laser microirradiation, etc.)

  • Fix cells at defined time points (0, 5, 15, 30, 60, 180 minutes post-damage)

  • Stain for NBA1 and other DNA damage response proteins (γ-H2AX, BRCA1, 53BP1)

  • Quantify foci formation, colocalization, and resolution kinetics

  • Generate temporal maps of protein recruitment and dissociation

• Live-cell imaging with fluorescently-tagged proteins:

  • Express fluorescently-tagged NBA1 (validated against antibody staining)

  • Perform real-time imaging following localized DNA damage

  • Track protein dynamics, residence time, and exchange rates

  • Correlate with cell cycle markers or DNA repair outcomes

• ChIP-sequencing for genomic localization:

  • Use NBA1 antibodies for chromatin immunoprecipitation

  • Sequence precipitated DNA to map genomic binding sites

  • Compare binding profiles before and after DNA damage

  • Integrate with transcriptomic data to identify functional outcomes

• FRAP (Fluorescence Recovery After Photobleaching) analysis:

  • Bleach NBA1-GFP at damage sites

  • Measure recovery kinetics to determine protein mobility and exchange rates

  • Compare dynamics under different genetic or pharmacological interventions

Research has shown that NBA1 relocates to DNA damage sites in response to both IR and UV laser microirradiation, colocalizing with markers such as BRCA1 and γ-H2AX. This recruitment pattern indicates that NBA1 plays a direct role in DNA damage sensing and/or repair processes, making it a valuable target for studying the dynamics of these cellular responses .

What factors might affect NBA1 antibody sensitivity and specificity in different applications?

Several factors can impact the sensitivity and specificity of NBA1 antibodies across different experimental applications:

• Antibody characteristics:

  • Clonality: Monoclonal antibodies offer higher specificity but may have lower sensitivity than polyclonal antibodies

  • Epitope location: Antibodies targeting functional domains may be affected by protein interactions

  • Affinity: Higher affinity antibodies generally provide better sensitivity

  • Production method: Different expression systems may affect glycosylation and folding

• Sample preparation factors:

  • Fixation methods: Overfixation can mask epitopes; underfixation can lose protein

  • Antigen retrieval: Critical for formalin-fixed samples but may introduce artifacts

  • Lysis conditions: Detergent type and concentration affect protein solubilization

  • Protein denaturation: Native vs. denatured detection requirements vary by antibody

• Technical variables:

  • Incubation temperature and time: Affect binding kinetics and background

  • Blocking agents: BSA vs. milk can result in different background patterns

  • Washing stringency: Too stringent may reduce signal; too gentle may increase background

  • Detection system sensitivity: Enzymatic vs. fluorescent detection thresholds

• Biological variables:

  • Post-translational modifications: Phosphorylation or ubiquitination may mask epitopes

  • Protein levels: Expression levels vary across cell types and conditions

  • Complex formation: NBA1 exists in protein complexes that may obscure epitopes

  • Isoform expression: Different cell types may express different NBA1 variants

Research has demonstrated that NBA1 associates with multiple proteins including Abra1, Rap80, BRE, and BRCC36 in the BRCA1 A complex, which may affect antibody accessibility to certain epitopes depending on the detection method used .

How can I determine whether my NBA1 antibody is detecting the correct protein in my experimental system?

To verify that your NBA1 antibody is detecting the correct protein target, implement these validation strategies:

• Primary validation approaches:

  • Genetic validation: Test antibody in NBA1 knockout or knockdown systems

    • Use multiple siRNAs/shRNAs targeting different regions of NBA1

    • Confirm signal reduction correlates with knockdown efficiency

    • Express shRNA-resistant NBA1 to rescue signal

  • Molecular weight verification: Confirm detection at the expected molecular weight (~40 kDa)

  • Multiple antibody concordance: Test different antibodies targeting distinct NBA1 epitopes

• Secondary validation approaches:

  • Mass spectrometry validation: Immunoprecipitate the detected protein and confirm identity

  • Recombinant protein controls: Compare signal to purified NBA1 protein

  • Tagged protein expression: Compare detection of endogenous protein with tagged version

• Functional validation strategies:

  • Response to DNA damage: Verify proper relocalization to damage sites after IR

  • Association with known partners: Confirm co-immunoprecipitation with established interactors

  • Phenotypic correlation: Check that antibody signal correlates with expected phenotypes

• Validation checklist:

  Validation Method	Expected Result
  Western blot after knockdown	Reduced band intensity at ~40 kDa
  IP-MS	Identification of NBA1/MERIT40 peptides
  IF after DNA damage	Nuclear foci formation
  Co-IP	Detection of Abra1, Rap80, BRE
  Phenotypic assay	Signal correlates with IR sensitivity

Research has demonstrated that NBA1 knockdown using shRNAs results in increased sensitivity to IR, which can be reversed by expressing shRNA-resistant NBA1 cDNA. This functional validation approach confirms the specificity of both the knockdown and the antibody detection of the correct protein .

What are common pitfalls when using NBA1 antibodies in protein complex studies?

Researchers should be aware of these common pitfalls when using NBA1 antibodies to study protein complexes:

• Complex disruption issues:

  • Harsh lysis conditions: Strong detergents or high salt concentrations can disrupt protein-protein interactions

  • Incorrect buffer pH: Non-optimal pH can destabilize complex integrity

  • Inappropriate extraction timing: Some complexes form transiently after stimulation

• Antibody interference problems:

  • Epitope masking: Antibody binding site may be obscured in the intact complex

  • Complex disruption by antibody: Antibody binding may destabilize certain interactions

  • Steric hindrance: Antibody may block access to interacting proteins

• Control and validation challenges:

  • Indirect associations: DNA or RNA can mediate apparent interactions

  • Post-lysis associations: Proteins may associate after cell disruption, not reflecting in vivo interactions

  • Background binding: High background can obscure true interactions

• Methodological solutions:

  • Use gentle lysis conditions optimized to preserve complexes

  • Include DNase/RNase treatments to eliminate nucleic acid-mediated interactions

  • Perform reciprocal IPs with antibodies against different complex components

  • Use crosslinking to stabilize transient interactions

  • Validate interactions through multiple methodologies (co-IP, PLA, FRET)

  • Include appropriate negative controls (IgG, irrelevant antibodies)

Research has shown that NBA1 is part of a multi-protein BRCA1 A complex with striking parallels to the lid complex of the 26S proteasome. The study demonstrated that NBA1 was identified through tandem affinity purification of both NBA1 itself and its interaction partner Abra1, confirming the association through multiple approaches. Additionally, the research revealed that NBA1 is required to maintain the abundance of BRE and Abra1, indicating complex interdependencies that must be considered when interpreting results .

How can NBA1 antibodies be utilized in multi-parametric analysis of DNA damage response pathways?

NBA1 antibodies can be incorporated into cutting-edge multi-parametric analyses of DNA damage response pathways through these advanced methodological approaches:

• Mass cytometry (CyTOF) applications:

  • Label NBA1 antibodies with rare earth metals

  • Simultaneously detect 30+ proteins in the DNA damage response network

  • Analyze at single-cell resolution to identify heterogeneous responses

  • Correlate NBA1 status with cell cycle markers and DNA damage indicators

  • Create high-dimensional maps of cellular states following damage

• Multiplexed immunofluorescence approaches:

  • Use spectral unmixing or sequential staining techniques

  • Visualize NBA1 alongside multiple DDR components (BRCA1, γ-H2AX, 53BP1, RAD51)

  • Quantify spatial relationships between proteins at damage sites

  • Track temporal dynamics of complex assembly/disassembly

• Single-cell proteogenomic integration:

  • Combine antibody-based protein detection with transcriptomic profiling

  • Correlate NBA1 protein levels with gene expression signatures

  • Identify regulatory relationships in the DNA damage response

  • Discover novel pathway components through network analysis

• High-content screening applications:

  • Use NBA1 antibodies in automated microscopy platforms

  • Screen chemical or genetic perturbations for effects on NBA1 localization

  • Quantify multiple parameters (foci number, intensity, colocalization)

  • Identify novel regulators of the BRCA1 A complex

Research has demonstrated that NBA1 colocalizes with BRCA1 at sites of IR-induced damage and also localizes to laser-induced DNA damage stripes that overlap with histone γ-H2AX. These localization patterns indicate NBA1's direct role in the DNA damage response network, making it a valuable marker for multi-parametric analyses of these pathways .

What are the implications of NBA1's role in the BRCA1 A complex for cancer research applications?

NBA1's critical role in the BRCA1 A complex has significant implications for cancer research applications using NBA1 antibodies:

• Biomarker development applications:

  • Prognostic potential: NBA1 antibodies can assess protein expression in tumor samples to correlate with patient outcomes

  • Treatment response prediction: NBA1 status may indicate sensitivity to PARP inhibitors or platinum-based chemotherapies

  • Subtype classification: NBA1 localization patterns might distinguish tumor subtypes with different DNA repair capacities

• Therapeutic target validation:

  • Synthetic lethality screening: NBA1 antibodies can validate knockdown efficiency in screens for vulnerabilities in DNA repair-deficient cancers

  • Drug mechanism studies: Monitor NBA1 complex formation/localization after treatment with DNA-damaging agents

  • Resistance mechanism identification: Track changes in NBA1 expression or complex formation in treatment-resistant cells

• Functional characterization in cancer models:

  • Tumor microenvironment effects: Study how hypoxia or inflammation affects NBA1 function

  • Metastatic potential correlation: Investigate whether NBA1 dysfunction correlates with genomic instability driving metastasis

  • Cancer stem cell biology: Examine NBA1 activity in cancer stem cell populations versus differentiated tumor cells

• Precision medicine applications:

  Cancer Type	NBA1 Research Application	Clinical Relevance
  Breast cancer	BRCA1/NBA1 complex integrity	PARP inhibitor eligibility
  Ovarian cancer	NBA1 expression in platinum resistance	Treatment selection
  Prostate cancer	DNA repair pathway activity	Genomic instability assessment

Research has shown that NBA1 plays a critical role in IR resistance, cell cycle regulation, and the recruitment of BRCA1 to sites of DNA damage. Given BRCA1's established role as a tumor suppressor gene, NBA1's function in the BRCA1 A complex makes it potentially important in cancer biology, particularly in contexts where DNA repair deficiencies drive oncogenesis or treatment response .

How might new antibody technologies enhance NBA1 research in the future?

Emerging antibody technologies offer exciting possibilities for advancing NBA1 research:

• Next-generation antibody formats:

  • Nanobodies: Single-domain antibodies providing enhanced access to sterically hindered epitopes in the NBA1 complex

  • Bispecific antibodies: Simultaneously targeting NBA1 and interaction partners for enhanced specificity

  • Intrabodies: Genetically encoded antibody fragments for tracking NBA1 in living cells

  • Optically-controlled antibodies: Light-activated binding for spatiotemporal control of NBA1 inhibition

• Advanced detection technologies:

  • Super-resolution compatibility: NBA1 antibodies optimized for STORM/PALM imaging to visualize nanoscale complex organization

  • Expansion microscopy applications: NBA1 antibodies compatible with protein retention during expansion

  • Correlative light-electron microscopy: NBA1 detection across scales from molecular complexes to cellular structures

  • Live-cell compatible antibody fragments: Real-time tracking of endogenous NBA1 without genetic modification

• Functional antibody applications:

  • Conformation-specific antibodies: Detecting NBA1 structural changes during complex assembly

  • Modification-specific antibodies: Recognizing phosphorylated or ubiquitinated forms of NBA1

  • Proximity-dependent labeling: Antibody-enzyme fusions for mapping the NBA1 interactome

  • Degrader antibody conjugates: Targeted degradation of NBA1 for acute functional studies

• High-throughput analysis platforms:

  • Antibody arrays: Parallel analysis of NBA1 and dozens of interaction partners

  • Single-molecule pull-down: Analyzing individual NBA1 complexes for compositional heterogeneity

  • Spatial transcriptomics integration: Correlating NBA1 protein localization with local gene expression

  • AI-augmented image analysis: Deep learning for complex pattern recognition in NBA1 localization studies

These emerging technologies will enable researchers to explore NBA1's role in the BRCA1 A complex with unprecedented resolution and functional insight. Given that current research has established NBA1's importance in DNA damage response through biochemical and cell biological approaches, these new technologies offer opportunities to address remaining questions about complex assembly dynamics, regulatory mechanisms, and functional consequences of NBA1 activity .